Chronic secretory otitis media
Conditions
Interventions
Experimental group1:Eustachian Tube Balloon Dilation
Experimental group2:Tympanic Tube Placement
Experimental group3:Eustachian Tube Balloon Dilation Combined with Tympanic Tube Placement
Sponsors
The Sixth Medical Center of PLA General Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1.Age 18 to 70 years (including borderline values), with no restriction on gender; 2.Patients diagnosed with chronic secretory otitis media, with no restriction on side, and those who meet the criteria in both ears can be included; (1) History of chronic secretory otitis media greater than 3 months; (2) Complete tympanic membrane with clear middle ear effusion on otoscopic examination; (3) Conductive deafness; (4) Acoustic conduction resistance with type B or C curve. 3.Negative for Valsalva; 4.History of previous tympanic membrane puncture or medication (nasal spray hormone and/or mucus promoter, etc.); 5.Patients who are to be treated with tympanic tube placement or eustachian tube balloon dilation for the first time and meet the indications for the surgery.
Exclusion criteria
Exclusion criteria: 1.Fluctuating sensorineural deafness; 2.Otoscopic examination of the tympanic membrane with adhesions to the tympanic capsule or the presence of otitis externa (oozing from the external ear canal, fungal infection, etc.); 3.Clear presence of abnormal opening of the eustachian tube or other eustachian tube diseases; 4.Eligible for surgical treatment due to other nasal, sinus or ear diseases; 5.History of surgery on the affected middle ear and nasal cavity or nasopharynx; 6.History of cleft palate or other deformities or related surgical repair; 7.History of head or neck surgery or radiation therapy; 8.Patients with ciliary immobility syndrome; 9.Expected survival for malignancy <12 months; 10.Patients with other conditions that, in the opinion of the investigator, are not suitable for participation in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of Eustachian Tube Score 12 months after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recovery rate of Valsalva test;Eustachian Tube Dysfunction Scale;Pure tone audiometry;Morphology of tympanic membrane;Clearance of middle ear effusion; | — |
Countries
China
Contacts
Public ContactHou Zhaohui
The Sixth Medical Center of PLA General Hospital
Outcome results
None listed